Hodges Capital Management Inc. Emergent Bio Solutions Inc. Transaction History

Hodges Capital Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 07, 2021	SELL	$86.23 - $125.19 $562,564 - $816,739	-6,524 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$79.17 - $111.47 $738,101 - $1.04 Million	-9,323 Reduced 58.83%	6,524 $585,000
Q3 2020 Oct 15, 2020	SELL	$81.91 - $134.94 $4.16 Million - $6.86 Million	-50,815 Reduced 76.23%	15,847 $1.64 Million
Q2 2020 Jul 22, 2020	BUY	$54.33 - $89.52 $1.63 Million - $2.69 Million	30,089 Added 82.27%	66,662 $5.27 Million
Q1 2020 May 04, 2020	BUY	$49.34 - $68.76 $1.8 Million - $2.51 Million	36,573 New	36,573 $2.12 Million
Q2 2018 Jul 26, 2018	SELL	$48.33 - $55.64 $1.45 Million - $1.67 Million	-30,000 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$44.44 - $54.39 $1.11 Million - $1.36 Million	-25,000 Reduced 45.45%	30,000 $1.58 Million
Q4 2017 Feb 06, 2018	SELL	$37.77 - $47.75 $944,250 - $1.19 Million	-25,000 Reduced 31.25%	55,000 $2.56 Million
Q3 2017 Nov 02, 2017	BUY	$34.14 - $40.45 $2.73 Million - $3.24 Million	80,000	80,000 $3.24 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hodges Capital Management Inc. with notifications on news.